A few articles on the benefits of Tumeric (curcumin) 1: Priyanka A, Anusree SS, Nisha VM, Raghu KG. Curcumin improves hypoxia induced dysfunctions in 3T3-L1 adipocytes by protecting mitochondria and down regulating inflammation. Biofactors. 2014 Aug 11. doi: 10.1002/biof.1175. [Epub ahead of print] PubMed PMID: 25110893. 2: Bora-Tatar G, Erdem-Yurter H. Investigations of Curcumin and Resveratrol on Neurite Outgrowth: Perspectives on Spinal Muscular Atrophy. Biomed Res Int. 2014;2014:709108. Epub 2014 Jul 2. PubMed PMID: 25105137. 3: Malik P, Ameta RK, Singh M. Preparation and characterization of bionanoemulsions for improving and modulating the antioxidant efficacy of natural phenolic antioxidant curcumin. Chem Biol Interact. 2014 Aug 7. pii: S0009-2797(14)00228-2. doi: 10.1016/j.cbi.2014.07.013. [Epub ahead of print] PubMed PMID: 25110318. 4: Elburki MS, Rossa C, Guimaraes MR, Goodenough M, Lee HM, Curylofo FA, Zhang Y, Johnson F, Golub LM. A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations. Mediators Inflamm. 2014;2014:959471. Epub 2014 Jun 29. PubMed PMID: 25104884. 5: Zaahkouk AM, Abdel Aziz MT, Rezq AM, Atta HM, Fouad HH, Ahmed HH, Sabry D, Yehia MH. Efficacy of a novel water-soluble curcumin derivative versus sildenafil citrate in mediating erectile function. Int J Impot Res. 2014 Aug 7. doi: 10.1038/ijir.2014.24. [Epub ahead of print] PubMed PMID: 25099638. 6: Berhanu WM, Masunov AE. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: Molecular Dynamics study of Curcumin, Exifone and Myricetin interaction with the segment of tau peptide oligomer. J Biomol Struct Dyn. 2014 Aug 5:1-52. [Epub ahead of print] PubMed PMID: 25093402. 7: Sareen R, Nath K, Jain N, Dhar KL. Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation. Biomed Res Int. 2014;2014:340701. doi: 10.1155/2014/340701. Epub 2014 Jul 1. PubMed PMID: 25093165; PubMed Central PMCID: PMC4100342. 8: Banerjee S, Sahoo AK, Chattopadhyay A, Ghosh SS. Recombinant IκBα-loaded curcumin nanoparticles for improved cancer therapeutics. Nanotechnology. 2014 Aug 29;25(34):345102. Epub 2014 Aug 5. PubMed PMID: 25091588. 9: Lv Y, An Z, Chen H, Wang Z, Liu L. Mechanism of curcumin resistance to human cytomegalovirus in HELF cells. BMC Complement Altern Med. 2014 Aug 4;14(1):284. [Epub ahead of print] PubMed PMID: 25088288. 10: Pan K, Luo Y, Gan Y, Baek SJ, Zhong Q. pH-driven encapsulation of curcumin in self-assembled casein nanoparticles for enhanced dispersibility and bioactivity. Soft Matter. 2014 Aug 1. [Epub ahead of print] PubMed PMID: 25082426. 11: Li Y, Peng P, Tang L, Hu Y, Hu Y, Sheng R. Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimers disease therapy. Bioorg Med Chem. 2014 Jul 12. pii: S0968-0896(14)00512-4. doi: 10.1016/j.bmc.2014.07.009. [Epub ahead of print] PubMed PMID: 25082512.
Posted on: Wed, 13 Aug 2014 02:04:39 +0000
Trending Topics
Recently Viewed Topics
© 2015